Neomycin: A novel potent blocker of communication between T-tubule and sarcoplasmic reticulum  by Yano, Masafumi et al.
FEBS Letters 351 (1994) 349-352 
FEBS 14482 
Neomycin: a novel potent blocker of communication between T-tubule and 
sarcoplasmic reticulum 
Masafumi Yano a, Roque E1-Hayek a, Bozena Antoniu a, Noriaki Ikemoto a,b,* 
aBoston Biomedical Research Institute, 20 Staniford Street, Boston, MA 02114, USA 
bDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA 
Received 16 May 1994; revised version received 25 July 1994 
Abstract Ca 2÷ release from the sarcoplasmic reticulum (SR) was induced in isolated triads by direct stimulation of the SR moiety by polylysine, 
or stimulation via chemical depolarization of the transverse tubule (T-tubule) moiety. Polylysine-induced release was blocked by neomycin with an 
IC50 (the concentration for half-maximal inhibition) of 0.3 pM. However, the IC50 for neomycin block of depolarization-induced Ca 2÷ release sharply 
decreased ina voltage-dependent fashion, and it was 5.3 nM at a maximal extent of T-tubule depolarization. These results uggest that the high affinity 
binding of neomycin to the triad leads to the specific blocking of the signal transmission from T-tubule to SR. 
Key words: Excitat ion-contract ion coupling; Triad; Specific inhibitor; Neomycin 
1. Introduction 
Several types of blockers of Ca 2+ release from the SR have 
been effectively used to characterize xcitat ion-contract ion 
(e-c) coupling properties of intact or skinned muscle fibers and 
isolated vesicles (reviews: [1-3]). One type, e.g. ruthenium red 
[4,5], directly blocks the ryanodine receptor (RyR)/Ca 2÷ chan- 
nel [6-8]. The other type, e.g. dihydropyridines, blocks the 
voltage-dependent signal transmission from T-tubule to SR, as 
evidenced by the inhibit ion of charge movement [9,10] and 
depolarization-induced SR Ca 2+ release with no effect on drug- 
induced Ca 2+ release [11]. Neomycin, like ruthenium red, inhib- 
its caffeine/polylysine- or Ca2+-induced Ca 2+ release at sub-/IM 
to several pM [12-14] by specifically binding to the RyR [14], 
indicating that neomycin is a specific blocker of the RyR/Ca 2+ 
channel. Here we report that neomycin works as a blocker of 
the RyR channel at sub- to several / IM,  while at much lower 
concentrat ions (1 nM-100 nM), it works as a specific blocker 
of the signal transmission from the T-tubule to the SR. 
2. Experimental 
2.1. Preparations 
The triad-enriched microsomal fraction (triad) was prepared from 
rabbit leg and back muscle by differential centrifugation asdescribed 
previously [15]. After the final centrifugation, the sedimented fraction 
was homogenized in a solution containing 0.3 M sucrose, 0.15 M K 
gluconate, proteolytic enzyme inhibitors (0.1 mM PMSF, 10/tg/ml 
aprotinin, 0.8/tg/ml antipain, 2/.tg/ml trypsin inhibitor), and 20 mM 
MES, pH 6.8 to a final protein concentration f 20-30 mg/ml. T-tubules 
and SR were separated by French press treatment of the triads, fol- 
lowed by sucrose density gradient centrifugation as described previ- 
ously [16]; purified T-tubules on top of the 27% sucrose layer were 
sedimented and homogenized in the same solution as above. The frac- 
tions were frozen immediately in liquid nitrogen, and stored at -70 ° C. 
*Corresponding author. Fax: (1) (617) 523 6649. 
Abbreviations." MES, 2-(N)morpholino)ethanesulfonic acid; PMSF, 
phenylmethyl sufonyl fluoride; RyR, ryanodine receptor; SR, sarco- 
plasmic reticulum; T-tubule, transverse tubular system. 
2.2. Ca e+ release assays 
For polylysine-induced Ca2+ release, triads (1 mg/ml) were incubated 
in a solution containing 150 mM KC1, 1 mM Mg-ATP, an ATP- 
regenerating system (5.0 mM phosphoenolpyruvate, 10 units/ml py- 
ruvate kinase), 50/.tM CaCI2, 20 mM MES, pH 6.8. After completion 
of Ca 2+ uptake into the SR, Ca 2÷ release was initiated by mixing one 
volume of the triad-containing solution with an equal volume of a 
solution containing 150 mM KCI, 6 pg/ml of 3.3 kDa polylysine, vari- 
ous concentrations of neomycin, and 20 mM MES, pH 6.8. The time 
course of polylysine-induced Ca2÷ release was monitored with 10 pM 
arsenazo III or 2.5 pM fluo-3 as a Ca 2÷ indicator using a stopped-flow 
apparatus (BioLogic SFM-3). 
To induce depolarization-induced Ca 2÷ release in the triads, we 
adopted the ionic replacement method (Na+ replacement protocol: for 
details, see the legend to Fig. 1) originally used to induce T-tubule- 
mediated contraction in the frog skinned muscle fiber system [17,18]. 
In fact, this ionic replacement procedure generated T-tubule membrane 
depolarization i  triads as shown by parallel measurements ofT-tubule 
depolarization and SR Ca 2÷ release [19]. First, triads (1.6 mg/ml) were 
incubated in a solution containing 150 mM K gluconate, 5 mM Mg- 
ATP, an ATP-regenerating system, 15 mM NaC1, and 150 pM CaC12, 
20 mM imidazole, pH 6.8. After incubation for at least 5 min to com- 
plete both T-tubule polarization (by mediation of the Na÷/K ÷ pump) 
and Ca 2÷ loading of the SR (by the SR Ca 2* pump), one volume of the 
primed (polarized and Ca 2÷ loaded) triad-containing solution was 
mixed with nine volumes of depolarization solution whose composi- 
tions are shown in Table 1. Various concentrations of neomycin were 
added to the depolarization solution. The time course of induced Ca 2÷ 
release was monitored using the stopped-flow spectrophotometric sys- 
tem using either 2.5/zM fluo-3 or 10/.tM arsenazo III as the Ca 2÷ 
indicator. The neomycin concentration-dependence of Ca2÷ release in- 
hibition was not affected by the type of Ca 2÷ indicator used. The initial 
rate of SR Ca 2÷ release was calculated by fitting exponential models to 
individual release curves (for details, see the legend to Table 2). 
2.3. [3H]Neomycin binding assay 
To prepare the [3H]neomycin probe, 125 pl stock solution of [3H]N- 
succinimidyl propionate (0.125 mCi, 2.05 nmol; New England Nuclear/ 
DuPont) was evaporated under nitrogen gas to remove the solvent, and 
50 pl solution of 40 pM neomycin in 20 mM HEPES (pH 7.5) was 
added, then incubated at 22°C for 1 h. Unreacted succinimidyl propion- 
ate was quenched with 1 mM lysine. For the assays of [3H]neomycin 
binding, 0.1 ml of T-tubule (1.0 mg/ml) or SR (3.2 mg/ml) vesicles, 
which had been primed in Solution A as described above, was mixed 
with 0.9 ml of depolarization solution (GI0) containing 10 nM [3H]ne- 
omycin. The mixture was immediately filtered through the Millipore 
filter (DA, 0.65/lm), air-dried and the radioactivity retained on the 
filter was scintillation-counted. Non-specific binding was determined 
by carrying out the same assays in the presence of 1.0 mM unlabeled 
neomycin added. 
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Fig. 1. Depolarization-induced Ca 2+ release is much more sensitive to 
the release inhibitor neomycin than polylysine-induced Ca 2÷ release. 
T-tubule depolarization was produced by mixing one volume of the 
primed triads with nine volumes of depolarization solution containing 
150 mM Na gluconate, 15 mM NaC1 (which gave the maximum grade 
of K* to Na + replacement (G10), see section 2) and various concentra- 
tions of neomycin as indicated. The time course of induced Ca 2÷ release 
was monitored using fluo-3 in the stopped-flow system. For the assay 
of polylysine-induced r lease, Ca2+-loaded triads were mixed with an 
equal volume of triggering solution containing 6/.tg/ml of polylysine 
(Mr = 3,300), and the release time course was monitored using arsenazo 
III in the stopped-flow system. Each trace was obtained by signal- 
averaging a total of 105-140 traces originating from 3-4 different exper- 
iments. 
3. R ~  
Addition of the maximally activating concentration of the 
RyR-specific trigger, polylysine (3 /.tg/ml = 0.9 /IM [20], or 
maximum extent of T-tubule depolarization (G10, see Table 1) 
yielded about the same magnitude of Ca 2÷ release, 70-80 nmol 
of Ca 2+ release/mg protein at 1 s (Fig. 1). However, the sensitiv- 
ity to the release blocker neomycin was found to be significantly 
different. Namely, polylysine-induced Ca2+ release was inhib- 
ited in the [neomycin] range of 0.3-3.0/.tM, the same concentra- 
tion range for the inhibition of caffeine- and Ca2÷-induced Ca 2+ 
release [12,13]. In sharp contrast, depolarization-induced Ca 2+ 
release was inhibited in a much lower concentration range 
(1-100 nM). Thus, 0.1 aM neomycin had virtually no effect on 
polylysine-induced Ca 2+ release, while it produced almost com- 
plete inhibition of depolarization-induced Ca 2+ release. The 
inhibition of Ca 2+ release by neomycin occurred instantane- 
ously, because neomycin was added only in the depolarization 
solution. These results suggest hat there are two classes of 
neomycin binding sites: one, the known channel blocking 
site(s), and the other, a new site(s) with much higher affinity 
that is involved in blocking the T-tubule-to-SR signal trans- 
mission and is highly accessible to the neomycin binding. 
The calculated values of the initial rate of Ca 2+ release are 
shown as a function of the neomycin concentration present 
during Ca 2+ release (Table 2, a and b; Fig. 2). The neomycin 
IC50 determined was 0.3 + 0.18 pM (mean _+ S.D., n = 3) for 
polylysine-induced Ca 2÷ release, and was as low as 5.3 + 4.2 nM 
(n = 4) for depolarization (G10)-induced Ca 2÷ release (the 
P value between polylysine and G10 = 0.020). The neomycin 
ICso for polylysine-induced Ca2÷ release was about the same 
when lower polylysine dose (0.3 pg/ml) was used. Interestingly, 
however, the neomycin ICs0 for depolarization-induced Ca 2÷ 
release varied significantly with the extent of T-tubule depolar- 
ization: 38 + 9.6 nM (n = 3) at G3.25, and 16 + 3.5 nM (n = 2) 
at G5.5, and 5.3 + 4.2 nM (n = 4) at G I0  as described above 
(the P value between G3.25 and G10 = 0.0016). 
As shown in Fig. 3, 0.1 aM neomycin produced almost com- 
plete inhibition of depolarization-induced Ca 2÷ release (panel 
b). Nevertheless, polylysine induced a normal amount of Ca 2÷ 
release in the presence of 0.1 aM (panel c), which is comparable 
to the amount of Ca 2÷ release by simultaneous application of 
both T-tubule depolarization and polylysine (panel d). This 
indicates that 0.1 /.tM or lower concentrations of neomycin 
specifically blocked the pathway by which the Ca 2÷ channel is 
activated via T-tubule depolarization with no effect on the 
mechanism of direct stimulation by the RyR-specific ligand 
polylysine. 
In order to examine the possibility that the high affinity 
neomycin binding site(s) might be in the T-tubule moiety, we 
determined the binding of [3H]neomycin to the purified T-tu- 
bule, and compared with that to the triad. At 10 nM [3H]neomy- 
cin (~ ICs0 for neomycin block of depolarization-induced Ca 2÷ 
release), the specific activity of neomycin binding to the purified 
T-tubule fraction (2.8 _+ 2.3 pmol/mg protein; n = l l from 
4 different preparations) was even smaller (P = 0.101) than that 
Table 1 
Composition of depolarization solution used to generate various extents of T-tubule depolarization 
Na gluconate K gluconate NaCI fluo-3 lmidazole 
(mM) (mM) (mM) (aM) (mM) 
G10 150 0 15 2.5 20 
G5.5 75 75 15 2.5 20 
G3.25 37.5 112.5 15 2.5 20 
The G values represent the ratios of ([Na+]c after mixing the priming solution with the depolarization solution)/([Na÷]c of the priming solution), where 
[Na÷]c is the concentration f Na+ in the reaction solution (c: cytoplasmic). The sum of [K÷]~ and 0Na*]c was kept constant before and after mixing. 
Therefore, [K+]~ decreased upon increasing the G value. The pH of the solution: 6.8. 
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Fig. 2. The effect of neomycin on the initial rate of SR Ca 2÷ release 
induced by polylysine (o), maximal depolarization ofT-tubule (o), and 
partial depolarization ofT-tubule (,,). The data shown in Table 2 were 
expressed as % control, and plotted as a function of neomycin concen- 
tration. Each datum point represents an average of 3-4 experiments 
+ S.D. 
to the triad (4.4 _+ 2.0 pmole/mg protein; n = 12 from 4 different 
preparations). Thus, the critical neomycin binding site(s) ap- 
pears to be localized in the SR side, rather than the T-tubule 
side, of  the signal transmission pathway (see section 4). 
4. Discussion 
Polylysine-induced release and depolarization-induced re- 
lease described in this study are mediated via two distinctly 
different mechanisms. The former release is produced by direct 
stimulation of the SR moiety [14,20]. The latter is presumably 
controlled by the membrane potential changes in the T-tubule 
moiety of the triad [ 17-19]. However, both types of Ca 2÷ release 
are probably mediated by a common channel that resides in the 
RyR protein [8]. 
The neomycin ICs0 value for the inhibition of polylysine- 
induced Ca 2+ release reported here (0.3/~M) is essentially iden- 
tical to the values reported in the literature for neomycin inhi- 
bition of SR Ca 2÷ release induced by caffeine (0.3/.tM, [12]) or 
by Ca 2+ (0.22-0.37 gM,  [12,13]), suggesting that at these con- 
centrations neomycin works as a blocker of  a common release 
channel for all types of Ca 2÷ release. If neomycin works primar- 
ily as the RyR-specific common channel blocker, depolariza- 
tion-induced Ca 2÷ release would have been inhibited in the 
same neomycin concentration range as for the polylysine- 
induced Ca 2÷ release. However, the neomycin ICs0 for depolar- 
ization-induced Ca 2+ release is much lower than that for po- 
lylysine-induced Ca 2÷ release. Furthermore, ICso varied in a 
voltage-dependent manner. The inhibition is not due to the 
perturbation of T-tubule polarization by neomycin, because 
neomycin was added after completion of T-tubule polarization. 
We propose that there is an additional neomycin (site)s, which 
has much higher affinity for neomycin than the RyR channel 
blocking site(s) and is located in an area of the triad critical for 
the T-tubule-to-SR communication. The putative high affinity 
neomycin binding site(s) must be located in the cytoplasmic 
surface of the triad, because the inhibition occurred instantane- 
ously upon mixing with neomycin. 
Concerning the location of the high affinity neomycin bind- 
Table 2a 
The initial rates (nmol Ca 2÷ release/mg protein/s) of SR Ca 2÷ release induced by maximal depolarization (G10) and partial depolarization (G3.25) 
of T-tubule in the presence of various concentrations of neomycin 
Type of Ca 2+ release Neomycin added ~M) 
0 0.003 0.01 0.03 0.05 0.1 0.3 
Depolarization-induced 408 + 200 212 + 54 177 + 108 89 + 76 87 + 94 32 + 37 
Ca 2+ release (GI0) 
(4) (4) (4) (4) (4) (4) 
Depolarization-induced 73 + 2 80 + 18 69 + 13 49 + 16 29 + 6 5 + 8 1 + 1 
Ca 2+ release (G3.25) 
(3) (2) (3) (3) (2) (3) (3) 
Table 2b 
The initial rates (nmol Ca 2÷ release/mg protein/s) of SR Ca 2÷ release induced by polylysine (3 pg/ml) in the presence of various concentrations of 
neomycin 
Type of Ca 2÷ release Neomycin added (tiM) 
0 0.03 0.1 0.3 1.0 3.0 
Polylysine-induced 282 + 119 274 + 128 223 + 96 134 + 60 44 _+ 40 22 _+ 30 
Ca 2÷ release 
(3) (3) (3) (3) (3) (3) 
Ca 2+ release by polylysine and by maximal depolarization were produced and monitored as described in the legend to Fig. I. For partial depolarization 
(G3.25), one volume of primed triads was mixed with nine volumes of depolarization solution (see Table 1) containing various concentrations of
neomycin. Then, the time course of release was monitored in the same way as for Ca 2+ release induced by maximal depolarization. The initial rates 
of Ca 2+ release (A "k) were calculated by fitting single {y = Yo + A (1 - e-k')} or double {y = Y0 + A~ (l - e-k1 ') + A 2 (l - e-k2')} exponential functions 
to the time course (obtained by signal averaging about 120 traces) of polylysine-induced and depolarization-induced Ca 2+ release, respectively. The 
rapid descending phase during the initial 20 ms in the time courses of both polylysine-induced Ca2÷ release and depolarization-induced Ca 2+ release 
represents a mixing artifact, because this phase was present under non-depolarizing conditions, in the absence of added polylysine, and in the presence 
of the release blocker. Thus, the initial 20 ms portion was excluded from the curve fitting. Data represent the mean _+ S.D. n: the number of 
experiments. 
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Fig. 3. Control experiments showing that polylysine is fully capable of 
inducing Ca 2÷ release (cf. panel c) even after complete inhibition of 
depolarization-induced Ca 2÷ release by 0.1/2M neomycin (cf. panel b). 
Ca 2÷ release was induced by the maximum extent of ionic replacement 
(GI0) with various combinations of addition of neomycin and polyly- 
sine as indicated. 
ing site(s), several possibilities remain to be investigated, such 
as the T-tubule membrane, the RyR, or a yet unidentified 
coupling protein located in the T-tubule/SR junction, etc. In 
view of the present finding that at 10 nM neomycin the specific 
activity of [3H]neomycin binding to the purified T-tubule frac- 
tion is smaller than that to the total fraction of triad, its specific 
localization in the T-tubule appears to be unlikely. Together 
with our recent finding that at low concentrations (< several 
#M) neomycin binds almost exclusively to the RyR [14], we 
tentatively propose that the new neomycin site(s) described 
here is localized in the RyR, viz. in the putative signal-receiving 
domain of the RyR. In conclusion, neomycin would serve as 
a new tool, for both biochemical and physiological studies of 
e-c coupling, especially to identify and characterize key pro- 
teins or domains involved in the signal transmission from 
T-tubule to SR. 
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